SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891618-02-001866
Filing Date
2002-04-19
Accepted
2002-04-19 00:00:00
Documents
3
Period of Report
2002-04-16
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f80918e8-k.htm 8-K 8764
3 EXHIBIT 99.1 f80918ex99-1.txt EX-99.1 3756
4 EXHIBIT 99.2 f80918ex99-2.txt EX-99.2 3384
  Complete submission text file 0000891618-02-001866.txt   17655
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 02616153
SIC: 2833 Medicinal Chemicals & Botanical Products